An assessment of antimicrobial consumption in food producing animals in Kenya

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

An assessment of antimicrobial consumption in food producing animals in Kenya. / Mitema, E S; Kikuvi, G M; Wegener, Henrik Caspar; Stohr, K.

I: Journal of Veterinary Pharmacology and Therapeutics Online, Bind 24, Nr. 6, 12.2001, s. 385-90.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Mitema, ES, Kikuvi, GM, Wegener, HC & Stohr, K 2001, 'An assessment of antimicrobial consumption in food producing animals in Kenya', Journal of Veterinary Pharmacology and Therapeutics Online, bind 24, nr. 6, s. 385-90.

APA

Mitema, E. S., Kikuvi, G. M., Wegener, H. C., & Stohr, K. (2001). An assessment of antimicrobial consumption in food producing animals in Kenya. Journal of Veterinary Pharmacology and Therapeutics Online, 24(6), 385-90.

Vancouver

Mitema ES, Kikuvi GM, Wegener HC, Stohr K. An assessment of antimicrobial consumption in food producing animals in Kenya. Journal of Veterinary Pharmacology and Therapeutics Online. 2001 dec.;24(6):385-90.

Author

Mitema, E S ; Kikuvi, G M ; Wegener, Henrik Caspar ; Stohr, K. / An assessment of antimicrobial consumption in food producing animals in Kenya. I: Journal of Veterinary Pharmacology and Therapeutics Online. 2001 ; Bind 24, Nr. 6. s. 385-90.

Bibtex

@article{ba97931f7dda43598f95bb9014435c3f,
title = "An assessment of antimicrobial consumption in food producing animals in Kenya",
abstract = "Antimicrobial agents are useful for control of bacterial infections in food animals and man. Their prudent use in these animals is important to control any possible development and transfer of resistance between animals and man. The objective of this study was to generate quantitative information to evaluate antimicrobial usage patterns by animal species, route of administration, antimicrobial class and type of use from 1995 to 1999 in Kenya. Theses data are essential for risk analysis and planning and can be helpful in interpreting resistance surveillance data, and evaluating the effectiveness of prudent use efforts and antimicrobial resistance mitigation strategies. Data on quantities of active substance classes were collected from the official records of the Pharmacy and Poisons Board of the Ministry of Health and analysed in MS Excel 2000 program. The mean antimicrobial consumption for the 5-year period was 14 594 +/- 1457 kg per year. This was distributed in the various antimicrobial classes as follows: 7975 kg (54.65%) of tetracyclines, 3103.96 kg (21.27%) of sulfonamides and 954.5 kg (6.56%) of aminoglycosides, 905 kg (6.20%) of beta-lactams, 94 kg (0.64%) of quinolones, 35 kg (0.24%) of macrolides and 24 kg (0.16%) of others (tiamulin). Mean consumption per year among the various food animals was: 10 989 +/- 357 kg in large animals (cattle, sheep, pigs and goats), 2906 +/- 127 kg in poultry alone and 699 +/- 427 kg in both large animals and poultry. These quantities represented 56.56% (8255 kg) consumption per year for parenteral use, 41.79% (6098 kg) for oral use and 1.65% (241 kg) for topical use (intramammary and eye ointments) in cattle. With respect to intended use in food producing animals, the mean consumption per year was: 13 178 kg (90.30%) for therapeutic use (ST), 4 kg (0.03%) for prophylactic treatment (PT) and 1411 +/- 246 kg (9.67%) was used both for therapeutic and prophylactic purposes (GPT). The study confirmed that antimicrobials are not used for growth promotion in Kenya. There was no specific trend in the quantities of active antimicrobial classes. This study has revealed that the tetracyclines, sulfonamides and trimethoprim, nitrofurans aminoglycosides, beta-lactams and the quinolones are the most commonly used drugs in food-producing animals in Kenya. Tetracyclines contributed approximately 55% of the total consumption, and there was an increasing trend in the consumption of quinolones from 1998.",
keywords = "Aminoglycosides, Animals, Anti-Infective Agents, Cattle, Diterpenes, Drug Residues, Drug Utilization, Goats, Humans, Kenya, Lactams, Macrolides, Quinolones, Sheep, Sulfonamides, Swine, Tetracyclines, Veterinary Drugs, Journal Article",
author = "Mitema, {E S} and Kikuvi, {G M} and Wegener, {Henrik Caspar} and K Stohr",
year = "2001",
month = dec,
language = "English",
volume = "24",
pages = "385--90",
journal = "Journal of Veterinary Pharmacology and Therapeutics",
issn = "1365-2885",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - An assessment of antimicrobial consumption in food producing animals in Kenya

AU - Mitema, E S

AU - Kikuvi, G M

AU - Wegener, Henrik Caspar

AU - Stohr, K

PY - 2001/12

Y1 - 2001/12

N2 - Antimicrobial agents are useful for control of bacterial infections in food animals and man. Their prudent use in these animals is important to control any possible development and transfer of resistance between animals and man. The objective of this study was to generate quantitative information to evaluate antimicrobial usage patterns by animal species, route of administration, antimicrobial class and type of use from 1995 to 1999 in Kenya. Theses data are essential for risk analysis and planning and can be helpful in interpreting resistance surveillance data, and evaluating the effectiveness of prudent use efforts and antimicrobial resistance mitigation strategies. Data on quantities of active substance classes were collected from the official records of the Pharmacy and Poisons Board of the Ministry of Health and analysed in MS Excel 2000 program. The mean antimicrobial consumption for the 5-year period was 14 594 +/- 1457 kg per year. This was distributed in the various antimicrobial classes as follows: 7975 kg (54.65%) of tetracyclines, 3103.96 kg (21.27%) of sulfonamides and 954.5 kg (6.56%) of aminoglycosides, 905 kg (6.20%) of beta-lactams, 94 kg (0.64%) of quinolones, 35 kg (0.24%) of macrolides and 24 kg (0.16%) of others (tiamulin). Mean consumption per year among the various food animals was: 10 989 +/- 357 kg in large animals (cattle, sheep, pigs and goats), 2906 +/- 127 kg in poultry alone and 699 +/- 427 kg in both large animals and poultry. These quantities represented 56.56% (8255 kg) consumption per year for parenteral use, 41.79% (6098 kg) for oral use and 1.65% (241 kg) for topical use (intramammary and eye ointments) in cattle. With respect to intended use in food producing animals, the mean consumption per year was: 13 178 kg (90.30%) for therapeutic use (ST), 4 kg (0.03%) for prophylactic treatment (PT) and 1411 +/- 246 kg (9.67%) was used both for therapeutic and prophylactic purposes (GPT). The study confirmed that antimicrobials are not used for growth promotion in Kenya. There was no specific trend in the quantities of active antimicrobial classes. This study has revealed that the tetracyclines, sulfonamides and trimethoprim, nitrofurans aminoglycosides, beta-lactams and the quinolones are the most commonly used drugs in food-producing animals in Kenya. Tetracyclines contributed approximately 55% of the total consumption, and there was an increasing trend in the consumption of quinolones from 1998.

AB - Antimicrobial agents are useful for control of bacterial infections in food animals and man. Their prudent use in these animals is important to control any possible development and transfer of resistance between animals and man. The objective of this study was to generate quantitative information to evaluate antimicrobial usage patterns by animal species, route of administration, antimicrobial class and type of use from 1995 to 1999 in Kenya. Theses data are essential for risk analysis and planning and can be helpful in interpreting resistance surveillance data, and evaluating the effectiveness of prudent use efforts and antimicrobial resistance mitigation strategies. Data on quantities of active substance classes were collected from the official records of the Pharmacy and Poisons Board of the Ministry of Health and analysed in MS Excel 2000 program. The mean antimicrobial consumption for the 5-year period was 14 594 +/- 1457 kg per year. This was distributed in the various antimicrobial classes as follows: 7975 kg (54.65%) of tetracyclines, 3103.96 kg (21.27%) of sulfonamides and 954.5 kg (6.56%) of aminoglycosides, 905 kg (6.20%) of beta-lactams, 94 kg (0.64%) of quinolones, 35 kg (0.24%) of macrolides and 24 kg (0.16%) of others (tiamulin). Mean consumption per year among the various food animals was: 10 989 +/- 357 kg in large animals (cattle, sheep, pigs and goats), 2906 +/- 127 kg in poultry alone and 699 +/- 427 kg in both large animals and poultry. These quantities represented 56.56% (8255 kg) consumption per year for parenteral use, 41.79% (6098 kg) for oral use and 1.65% (241 kg) for topical use (intramammary and eye ointments) in cattle. With respect to intended use in food producing animals, the mean consumption per year was: 13 178 kg (90.30%) for therapeutic use (ST), 4 kg (0.03%) for prophylactic treatment (PT) and 1411 +/- 246 kg (9.67%) was used both for therapeutic and prophylactic purposes (GPT). The study confirmed that antimicrobials are not used for growth promotion in Kenya. There was no specific trend in the quantities of active antimicrobial classes. This study has revealed that the tetracyclines, sulfonamides and trimethoprim, nitrofurans aminoglycosides, beta-lactams and the quinolones are the most commonly used drugs in food-producing animals in Kenya. Tetracyclines contributed approximately 55% of the total consumption, and there was an increasing trend in the consumption of quinolones from 1998.

KW - Aminoglycosides

KW - Animals

KW - Anti-Infective Agents

KW - Cattle

KW - Diterpenes

KW - Drug Residues

KW - Drug Utilization

KW - Goats

KW - Humans

KW - Kenya

KW - Lactams

KW - Macrolides

KW - Quinolones

KW - Sheep

KW - Sulfonamides

KW - Swine

KW - Tetracyclines

KW - Veterinary Drugs

KW - Journal Article

M3 - Journal article

C2 - 11903868

VL - 24

SP - 385

EP - 390

JO - Journal of Veterinary Pharmacology and Therapeutics

JF - Journal of Veterinary Pharmacology and Therapeutics

SN - 1365-2885

IS - 6

ER -

ID: 172849050